BOC Group/Ohmeda suits v. Inhalon employees seek to bar marketing of generic isoflurane, enflurane.
Executive Summary
BOC GROUP/OHMEDA SUING INHALON AND EMPLOYEES OVER 39424ISOFLURANE AND ENFLURANE, charging breach of contract by four former Ohmeda employees, conspiracy and misappropriation and misuse of trade secrets to manufacture the inhalation anesthetics. BOC Group, its Ohmeda Pharmaceutical Products Division anesthetics operations (formerly Anaquest) and its Puerto Rico manufacturing arm Ohmeda Caribe announced March 29 that suits have been filed against Bethlehem, Penn.-based Inhalon Pharmaceuticals in the Court of Common Pleas in Northampton County, Penn. that seek monetary damages and an injunction to prevent Inhalon from marketing isoflurane and enflurane.